Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis.

MLA

Guo, Xiao-Jun, et al. “Loss of 5-Hydroxymethylcytosine Induces Chemotherapy Resistance in Hepatocellular Carcinoma via the 5-HmC/PCAF/AKT Axis.” Cell Death & Disease, vol. 14, no. 2, Feb. 2023, pp. 1–13. EBSCOhost, https://doi.org/10.1038/s41419-022-05406-3.

APA

Guo, X.-J., Huang, X.-Y., Yang, X., Lu, J.-C., Wei, C.-Y., Gao, C., Pei, Y.-Z., Chen, Y., Sun, Q.-M., Cai, J.-B., Zhou, J., Fan, J., Ke, A.-W., Shi, Y. G., Shen, Y.-H., Zhang, P.-F., Shi, G.-M., & Yang, G.-H. (2023). Loss of 5-hydroxymethylcytosine induces chemotherapy resistance in hepatocellular carcinoma via the 5-hmC/PCAF/AKT axis. Cell Death & Disease, 14(2), 1–13. https://doi.org/10.1038/s41419-022-05406-3

Chicago

Guo, Xiao-Jun, Xiao-Yong Huang, Xuan Yang, Jia-Cheng Lu, Chuan-Yuan Wei, Chao Gao, Yan-Zi Pei, et al. 2023. “Loss of 5-Hydroxymethylcytosine Induces Chemotherapy Resistance in Hepatocellular Carcinoma via the 5-HmC/PCAF/AKT Axis.” Cell Death & Disease 14 (2): 1–13. doi:10.1038/s41419-022-05406-3.